Clinical trial
Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin (N-GAL) Evaluation of Symptomatic Heart Failure Study (AKINESIS)
NCT01291836 is registered in ClinicalTrials.gov with Alere San Diego as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin (N-GAL) Evaluation of Symptomatic Heart Failure Study (AKINESIS)
- Lead sponsor
- Alere San Diego
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2010
- Completion date
- June 30, 2015
- Enrollment
- 930 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
acute decompensated heart failure, acute kidney injury